FANJ
PACB icon

Financial Architects (New Jersey)’s Pacific Biosciences PACB Stock Holding History

Financial Architects (New Jersey)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,603
Closed -$223K – 340
2020
Q4 		$223K Buy
+8,603
New +$146K 0.04% 276
2019
Q2 		– Sell
-2,200
Closed -$16K – 1390
2019
Q1 		$16K Hold
2,200
– – ﹤0.01% 968
2018
Q4 		$16K Hold
2,200
– – ﹤0.01% 870
2018
Q3 		$12K Buy
+2,200
New +$9.44K ﹤0.01% 1067

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Financial Architects (New Jersey)'s PACB Position: Q1 2021 in Review

Financial Architects (New Jersey) sold out of Pacific Biosciences (PACB) in Q1 2021, closing a stake of 8,603 shares — an estimated $223K sold.

Financial Architects (New Jersey) first reported a position in PACB in Q3 2018 and held it in 4 quarters. The position peaked at $223K in Q4 2020. 262 funds tracked by Wall St. Rank hold PACB as of Q1 2021.

  • Financial Architects (New Jersey) reported no remaining Pacific Biosciences position as of Q1 2021 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 8,603 Pacific Biosciences shares in Q1 2021, an estimated $223K.
  • Financial Architects (New Jersey) first reported a position in Pacific Biosciences in Q3 2018 and held it in 4 quarters.
  • Financial Architects (New Jersey)'s Pacific Biosciences position peaked at $223K in Q4 2020.
  • 262 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2021.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2021, filed 17 May 2021.